MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
ADCT ADC Therapeutics
- 1.960
- -0.160-7.55%
Close Dec 20 16:00 ET
- 2.050
- +0.090+4.59%
Post 20:01 ET
189.51MMarket Cap-0.82P/E (TTM)
2.180High1.940Low1.90MVolume2.070Open2.120Pre Close3.78MTurnover2.47%Turnover RatioLossP/E (Static)96.69MShares6.04052wk High-1.10P/B150.60MFloat Cap1.45052wk Low--Dividend TTM76.83MShs Float56.590Historical High--Div YieldTTM11.32%Amplitude0.360Historical Low1.995Avg Price1Lot Size
ADC Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 27.40%18.46M | -9.71%17.41M | -4.94%18.05M | -66.86%69.56M | -75.94%16.79M | -81.01%14.49M | 11.52%19.28M | -59.16%18.99M | 518.89%209.91M | 310.34%69.8M |
| Operating revenue | 27.40%18.46M | -9.71%17.41M | -4.94%18.05M | -66.86%69.56M | -75.94%16.79M | -81.01%14.49M | 11.52%19.28M | -59.16%18.99M | 518.89%209.91M | 310.34%69.8M |
| Cost of revenue | 309.13%851K | 7.51%1.22M | 9,396.30%2.51M | -23.39%2.53M | 254.12%1.22M | -83.94%208K | -50.04%1.13M | -105.10%-27K | 136.97%3.3M | -202.47%-789K |
| Gross profit | 23.30%17.61M | -10.79%16.19M | -18.28%15.54M | -67.56%67.03M | -77.94%15.57M | -80.96%14.29M | 20.81%18.15M | -58.63%19.02M | 535.24%206.61M | 334.65%70.59M |
| Operating expense | 5.42%52.91M | -21.87%44.91M | -29.21%48.91M | -29.59%232.08M | -31.65%55.32M | -35.67%50.19M | -31.83%57.49M | -19.97%69.09M | 12.15%329.59M | 2.64%80.93M |
| Selling and administrative expenses | -11.47%20.68M | -20.86%20.94M | -24.09%23.42M | -26.21%105.89M | -25.27%25.22M | -35.95%23.35M | -11.86%26.46M | -17.46%30.85M | 5.32%143.49M | -7.61%33.75M |
| -Selling and marketing expense | -37.08%5.06M | -41.77%4.85M | -20.21%5.81M | -7.68%33.01M | -0.68%9.28M | -2.44%8.04M | -10.04%8.33M | --7.28M | --35.75M | --9.35M |
| -General and administrative expense | 1.96%15.62M | -11.25%16.09M | -25.29%17.61M | -32.36%72.88M | -34.68%15.94M | -45.73%15.32M | -12.67%18.13M | -36.95%23.57M | -20.92%107.74M | -33.19%24.4M |
| Research and development costs | 20.02%32.5M | -22.48%24.3M | -32.94%25.74M | -31.82%127.13M | -35.87%30.33M | -35.02%27.08M | -35.43%31.34M | -21.61%38.38M | 18.01%186.46M | 11.30%47.29M |
| Other taxes | -9.43%-267K | -1.59%-320K | -76.43%-247K | -161.90%-935K | -108.85%-236K | -100.00%-244K | -176.32%-315K | -1,650.00%-140K | 2.46%-357K | 35.80%-113K |
| Operating profit | 1.69%-35.3M | 26.98%-28.72M | 33.36%-33.37M | -34.20%-165.05M | -284.28%-39.74M | -1,100.03%-35.91M | 43.24%-39.33M | -24.07%-50.07M | 52.94%-122.99M | 83.48%-10.34M |
| Net non-operating interest income expense | 4.29%-9.68M | -18.76%-9.43M | -17.64%-9.55M | -4.75%-35.79M | 58.87%-9.62M | 8.75%-10.11M | 9.65%-7.94M | -189.28%-8.12M | -86.95%-34.16M | -146.17%-23.39M |
| Non-operating interest income | 27.19%3.44M | 37.14%3.25M | 35.54%2.95M | 310.44%10.54M | 120.53%3.29M | 890.11%2.7M | 14,725.00%2.37M | -88.12%2.18M | 3,790.91%2.57M | -80,245.00%-16.03M |
| Non-operating interest expense | 2.35%13.12M | 22.99%12.68M | 21.43%12.5M | 26.12%46.33M | 75.47%12.91M | 12.86%12.82M | 17.13%10.31M | 11.65%10.29M | 100.28%36.73M | -22.72%7.36M |
| Other net income (expense) | 120.29%1.36M | 145.22%2.43M | -510.10%-2.84M | -47.58%5.42M | -55.62%9.49M | 101.65%616K | -142.18%-5.38M | -94.84%693K | -63.26%10.33M | 35.73%21.38M |
| Gain on sale of security | -46.15%21K | 103.78%204K | -650.53%-3.11M | -100.20%-52K | 84.87%-54K | 100.83%39K | -136.80%-5.4M | -96.46%564K | -26.60%25.54M | -101.93%-357K |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---42.11M | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --42.11M | --0 |
| Other non- operating income (expenses) | 131.54%1.34M | 11,050.00%2.23M | 103.88%263K | -79.67%5.47M | -37.17%9.54M | -95.08%577K | --20K | --129K | --26.91M | --15.19M |
| Income before tax | 3.93%-43.62M | 32.17%-35.71M | 20.41%-45.76M | -33.10%-195.42M | -222.95%-39.87M | 11.53%-45.4M | 19.39%-52.65M | -222.43%-57.49M | 41.62%-146.82M | 78.09%-12.35M |
| Income tax | 205.88%90K | 105.20%234K | -68.53%163K | 17,127.31%39.11M | 1,313.13%43.17M | 88.05%-85K | -374.97%-4.5M | 144.27%518K | 101.06%227K | 113.90%3.06M |
| Earnings from equity interest net of tax | 81.55%-260K | 22.16%-597K | 49.60%-687K | 45.18%-5.53M | ---1.99M | ---1.41M | ---767K | ---1.36M | ---10.08M | ---- |
| Net income | 5.90%-43.97M | 25.30%-36.54M | 21.50%-46.61M | -52.78%-240.05M | -233.65%-85.03M | 7.67%-46.73M | 24.00%-48.92M | -256.37%-59.37M | 31.69%-157.13M | 25.87%-25.49M |
| Net income continuous Operations | 5.90%-43.97M | 25.30%-36.54M | 21.50%-46.61M | -52.78%-240.05M | -233.65%-85.03M | 7.67%-46.73M | 24.00%-48.92M | -256.37%-59.37M | 31.69%-157.13M | 25.87%-25.49M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 5.90%-43.97M | 25.30%-36.54M | 21.50%-46.61M | -52.78%-240.05M | -233.65%-85.03M | 7.67%-46.73M | 24.00%-48.92M | -256.37%-59.37M | 31.69%-157.13M | 25.87%-25.49M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 5.90%-43.97M | 25.30%-36.54M | 21.50%-46.61M | -52.78%-240.05M | -233.65%-85.03M | 7.67%-46.73M | 24.00%-48.92M | -256.37%-59.37M | 31.69%-157.13M | 25.87%-25.49M |
| Basic earnings per share | 26.32%-0.42 | 36.67%-0.38 | 23.29%-0.56 | -46.27%-2.94 | -246.67%-1.04 | 12.31%-0.57 | 28.57%-0.6 | -231.82%-0.73 | 33.00%-2.01 | 33.33%-0.3 |
| Diluted earnings per share | 26.32%-0.42 | 36.67%-0.38 | 23.29%-0.56 | -46.27%-2.94 | -246.67%-1.04 | 12.31%-0.57 | 28.57%-0.6 | -231.82%-0.73 | 33.00%-2.01 | 33.33%-0.3 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.